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Abstract
Mass spectrometry based clinical proteomics has emerged as a powerful tool for high-
throughput protein profiling and biomarker discovery. Recent improvements in mass spec-
trometry technology have boosted the potential of proteomic studies in biomedical research.
However, the complexity of the proteomic expression introduces new statistical challenges in
summarizing and analyzing the acquired data. Statistical methods for optimally processing
proteomic data are currently a growing field of research. In this paper we present simple, yet
appropriate methods to preprocess, summarize and analyze high-throughput MALDI-FTICR
mass spectrometry data, collected in a case-control fashion, while dealing with the statistical
challenges that accompany such data. The known statistical properties of the isotopic distri-
bution of the peptide molecules are used to preprocess the spectra and translate the proteomic
expression into a condensed data set. Information on either the intensity level or the shape of
the identified isotopic clusters is used to derive summary measures on which diagnostic rules
for disease status allocation will be based. Results indicate that both the shape of the identified
isotopic clusters and the overall intensity level carry information on the class outcome and can
be used to predict the presence or absence of the disease.
KEY WORDS: Clinical mass-spectrometry based proteomics, Fourier transform mass spec-
trometry, Isotopic distribution, Prediction
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1 Introduction
Mass spectrometry (MS) based clinical proteomics has emerged as a powerful analytical tool
for protein profiling of patient body fluids. It is widely used in cancer-associated marker dis-
covery, with the aim to better understand the specific disease as well as to exploit diagnostic,
prognostic and therapeutic potential. Proteomic methods can be used for the comparison of
protein profiles, consisting of high-dimensional features (peaks), of which the presence or in-
tensity can depend on the physiological and pathological condition of the individual. Examples
are case-control studies for the construction of diagnostic rules or prognostic studies for the
prediction of the disease outcome. Statistical analysis of data collected in the context of such
studies offers the opportunity to improve detection ability and facilitate early diagnosis and
prognosis.
Most often, peptide and protein analysis by MS occurs either through electrospray ion-
ization (ESI) or via matrix-assisted laser desorption/ionization (MALDI). Whereas ESI yields
multiply charged species, MALDI (predominantly) results in singly charged species. In this
study MALDI mass spectra are considered. These spectra, or profiles, can be obtained via
coupling with a time-of-flight mass analyzer (MALDI-TOF) or with a Fourier transform ion
cyclotron resonance system (MALDI-FTICR). There are inherent challenges in characteriz-
ing protein expression levels with regard to sensitivity and reproducibility (Diamandis, 2004,
Anderson and Anderson, 2002). Different types of mass spectrometers vary in their ability to
overcome these challenges. Fourier-transform (FT)-based technologies have shown to be pro-
vide powerful approaches for obtaining biomarker signatures. Particularly Fourier-transform
MS-platforms are extremely powerful for the analysis of complex mixtures. The main ad-
vantages of using this technology, compared to TOF-MS, are related to 1) the ultrahigh mass
resolving power (routinely more than 100,000) which allows the analysis of large proteins and
complex mixtures, 2) the mass accuracy and precision which allow more reliable identification
of the detected species and 3) the wide dynamic range which is favorable for the detection of
low abundant components.
Although various approaches on preprocessing and interpreting high - resolution mass
spectral data have been reported previously (Senko et al., 1995, Rockwood and Haimi, 2006,
Palmblad et al., 2001, Valkenborg et al., 2012, van der Burgt et al., 2007), these have been
used for the analysis of single spectra only, hence none of these has ever been evaluated in
the context of clinical applications, particularly in the case of class calibration and prediction
problems.
The main focus of this paper is to introduce an overview of methods to preprocess, sum-
marize and analyze high-throughput MALDI-FTICR mass spectrometry data, collected in the
context of a pancreatic cancer case-control study, while dealing with the statistical challenges
which accompany this specific type of data. We propose a computationally simple and fast
method to preprocess the raw spectra and translate the proteomic expression into a condensed
data set. Our approach uses the fact that in a MALDI spectrum singly charged species are
spaced 1 mass unit within each isotopic distribution. Using this property, the complete ex-
pression in the individual spectra can be reduced to clusters of isotopic expression on which
summary measures can be defined. For the remainder of the paper, we will refer to the de-
rived clusters as isotopic clusters, and to the expression within each isotopic cluster as isotopic
cluster pattern. We investigate various ways of summarizing the observed isotopic cluster pat-
tern with the ultimate goal to evaluate the different choices with respect to their predictive
capacity. To derive the summary measures we use information on either the intensity or the
shape of the observed isotopic cluster pattern. In this way we investigate whether there is ad-
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ditional information in the shape of the isotopic cluster patterns which can be used to predict
the health status of future patients. We finally explore the potential of improving predictions
by combining both intensity and shape.
The structure of the article is as follows: In Section 2 we will briefly overview the data
and its properties. The procedure employed to preprocess the raw data is then presented, fol-
lowed by an overview of the methods used to summarize the proteomic profiles. In Section
3 a comparative analysis of the proposed summary measures is presented in terms of their
predictive ability. We assess the impact of the different choices on class calibration and pre-
diction, by using the proposed summary measures as input variables into ridge regression, and
by evaluating the predictive performance of the resulting discriminating rules. Moreover, we
investigate the pure information of shape by isolating the shape information from the intensity
information. Finally the predictive potential of diagnostic rules based on integrating both types
of information will be exploited.
2 Materials and Methods
2.1 Data description
We consider a case-control study, the design of which is described in detail in Nicolardi et al.
(2014). The experiment involves a total of 273 individuals, consisting of 88 pancreatic cancer
patients and 185 healthy volunteers. From each of the included individuals, a serum sam-
ple was collected, stored and processed according to a standardized protocol. The original
study was set up to define a calibration set and a separate validation set, the samples of which
were collected in a later period than the samples of the calibration set. More specifically, for
the calibration set, serum samples were collected from 49 pancreatic cancer patients prior to
surgery and 110 healthy controls (age- and gender- matched) over a time period ranging from
October 2002 until December 2008 at the outpatient clinic of the Leiden University Medical
Center (LUMC), the Netherlands. For the validation set, serum samples were collected from
39 pancreatic cancer patients who were selected candidates for curative surgery and 75 healthy
(age- and gender- matched) controls over the time period ranging from January 2009 until July
2010. The available samples from both calibration and validation sets were distributed over
three distinct MALDI-target plates as follows: the first plate contained 96 samples (59 controls
vs. 27 cases) from the calibration set, the second plate contained 96 samples (60 controls vs.
36 cases) from the validation set and the last plate contained the remaining 63 samples from
the calibration set (41 controls vs. 22 cases) as well as the remaining 18 samples from the
validation set (15 controls vs. 3 cases). Cases and controls were randomly allocated to each
distinct plate using the above design. Sample placement on the plates was also randomized
between cases and controls using a randomized block design. Each sample was spotted in two
replicates onto the MALDI-target plate and mass-analyzed by a MALDI-FTICR MS system
which was optimized with regard to both sensitivity and resolving power. Each mass spectrum
was obtained from the sum of 10 scans of 150 laser shots each and stored on a grid of 512
K data points, covering the mass/charge range from 1013 to 3700 Da. The output MALDI-
FTICR profiles were exported as separate files for each individual, containing mass/charge
(m/z) values with their corresponding intensities.
Figure 1 shows an example of a mass spectrum of a case sample from the calibration set. A
mass spectrum consists of peaks with a certain intensity (i.e. height) distributed over a m/z-axis
generated from the detection of ionized molecules. In ultrahigh-resolution mass spectrometry,
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each species (such as a peptide) with a given elemental composition is detected as a cluster of
isotopic peaks resulting from the distribution of naturally occurring elements. These isotopic
peaks originate from ions with identical molecular formulas, but with different combinations
of atoms containing additional neutrons. For example, 12C, 13C and 14C are three isotopes
of the element carbon with atomic masses 12, 13 and 14 mass units respectively. The atomic
number of carbon is 6, which means that every carbon atom has 6 protons, so that the neutron
numbers of these isotopes are 6, 7 and 8 respectively. In a mass spectrum, the successive
isotopic peaks of a singly-charged species are approximately 1 Da apart and form a so-called
isotopic cluster. With high-resolution devices, isotopic clusters of peaks can be completely
resolved, whereas for low-resolution devices, the same clusters would appear as a single peak
in the mass spectrum. Superimposed in Figure 1 we plot an isotopic cluster at position m/z
2021.2 .
2.2 Identification Algorithm - Data preprocessing
In this section we describe a procedure to preprocess the raw data and to translate the isotopic
expression in the individual spectra into a condensed data set. The objective is to identify
isotopic clusters and quantify their corresponding isotopic peaks. The algorithm we propose is
particularly relevant in the context of large-scale clinical studies as it is simple and fast, and it
relies solely on the known statistical properties of MALDI-FTICR MS data, in particular that
successive isotopic peaks of a peptide molecule are commonly separated by 1 Da. Thus, it
can be applied fast across many spectra from different patients. The identification algorithm
finds m/z positions of peaks which belong to isotopic clusters in a completely non-parametric
fashion, thus avoiding any computationally intensive steps like model fitting to the observed
spectra.
The preprocessing procedure consists of four main steps: detection of peaks, identification
of isotopic clusters, alignment of the peaks within identified clusters and determination of peak
intensities. In the first step, the procedure operates on every sample separately and finds peak
locations of potential isotopes. In the second step, the procedure operates across all available
samples and assigns the identified peak locations obtained from the first step to clusters via
hierarchical clustering. In the third step the peaks within each cluster are aligned to represent
the same biological peak within the same cluster. In the final step, the procedure operates on
each individual spectrum, records and quantifies the peaks which are common with those from
the consensus list of the previous step.
To identify peak locations of isotopes for each sample, we first select all m/z values of
which the corresponding intensity values exceed a certain threshold. The threshold was defined
as the noise threshold from a visual inspection of a random sample of individuals’ spectra. This
selection removes on the one hand noisy signal and on the other reduces the number of data
points in each sample. We retain the m/z values above the specified threshold, resulting in
a set of g connected intervals which we denote by (Ig)g=1,...,G. Within each interval Ig, we
determine the m/z value xg corresponding to the maximum intensity value. For each patient
we thus have a list (xg)g=1,...G of peak locations, and for each peak location xg we have a
corresponding interval Ig. Of the resulting list we only retain all xg for which either xg+1 or
xg− 1 is also within another connected interval Ig′ . As we except the proteome to express in
isotopic clusters, this assures that the list contains all xg values which are likely to correspond
to successive peak locations within isotopic clusters as opposed to single (noisy) peaks along
the mass spectrum. In this way we obtain for each ith patient a list of xig values, corresponding
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to locations of consecutive isotopic peaks.
To identify clusters of peaks belonging to the same isotope clusters across individuals, we
consider the following basic relation:
xig ∼ xi′g′ if for some k ∈ {−1,0,1} : |xig− (xi′g′− k)|< δ , (1)
on the union of all peak lists across all patients, and define clusters as connected components
when viewing this relation as a graph on this set. Computationally, we approach this by ap-
plying single linkage clustering, regarding the above relation as a similarity measure with the
value 1 when the relation is present and 0 otherwise, making thus use of the well known rela-
tion between single linkage clustering and the minimum spanning tree.
Within each cluster we define a secondary relation on xig by:
xig ∼ xi′g′ if |xig− xi′g′ |< δ ′ (2)
and group peaks, again by considering the connected components of this relation. We choose
δ ′ so that the minimal distance between the resulting intervals is larger than 0.5. We finally
extract the centroid of each peak - the average value of xig for each sub-cluster in each cluster
- to represent the “consensus” position for that peak within that cluster across all spectra.
The above procedure results in a list of clusters (Cq)q=1,...,Q and a list of ordered peak
positions (xq j) j=1,...Jq within each cluster with distance roughly 1 Da between neighbouring
elements. Given the list of common peak positions from the clustering step, we record for
each individual spectrum all the intervals I from the detection step which include one of the
xq j values of our list. We quantify the peaks at the identified locations xq j in the individual
spectra by integrating the area under the intensity curve over I. Hence, for peak j in cluster q
and patient i we can either find such an interval in the patients’ list of intervals (an event which
we denote in the following by δiq j = 1) and have a corresponding intensity level yiq j, or fail
to find such an interval (δiq j = 0). In the following, we call a peak j undetectable in cluster q
and patient i, if δiq j = 0. We call a cluster q undetectable in patient i if δiq j = 0 for all peaks
j of the cluster. Each of these possible situations are shown in Figure 2, where we plot an
identified isotopic cluster at 2553 m/z for three different samples. While the isotopic cluster
is completely observed in the first sample, the very same cluster is only partly observed in the
second sample and completely non-observed in the third sample.
Ideally, each identified isotopic cluster corresponds to one unique isotopic distribution.
Nevertheless, since the algorithm is using the distance along the m/z axis to identify isotopic
clusters, we must allow for the risk of joining two distinct isotopes into the same cluster.
This issue may arise for instance in the situation where the distance between two consecutive
peaks belonging to different isotope distributions is approximately 1 Da. Hence, we suggest to
inspect the identified clusters for signs of bimodal patterns prior to any further analysis.
2.3 Summary measures
In this section we present a non-exhaustive overview of simple measures to summarize the
proteomic expression, detected for one isotopic cluster in one patient, in a meaningful way.
In particular, we consider summary measures which aim to estimate the intensity level or the
shape of the observed isotopic cluster pattern.
Notation In the following we omit subscript q and consider one cluster consisting of J
peaks, where J is cluster-specific. While some of our summary measures will be directly
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based on the indicators δi j, most of them will be based on assuming yi j is known for all pa-
tients. Hence, if δi j = 0, we code yi j as the area under the intensity curve in a systematic
interval around x j with length corresponding to the typical peak width in a specific m/z range.
The typical peak width is estimated as the average length of the connected intervals includ-
ing x j. Moreover, we denote with li j = logyi j the log-transformed peak intensity and with
l¯ j := 1n ∑i li j the typical/expected peak intensity, defined as the average of the log intensities
across all samples.
2.3.1 Intensity summary measures
Binary coding method We consider that the isotopic response in the pancreatic cancer
data is often partly or entirely undetectable across and within patients. A simple procedure
to summarize the isotopic expression is to recode the original data into present/absent type of
data, at either the peak or the isotopic cluster level. We investigate if the present/absent status
is informative at the peak level, by ignoring yi j and using the binary indicator δi j, with 1 if
a peak is detected and 0 if a peak is undetectable. To investigate if the present/absent status
is informative at the cluster level, we follow a similar approach and recode the data to 1 if
a cluster is completely or partly detected and 0 if a cluster is completely undetectable. We
consider the binary method as a reduced version of a data-summary approach, in the context
of which we reduce the information in the original intensity measures to present/absent type
of measures rather than considering directly the absolute intensities themselves.
Ranking method An extension to the binary method, familiar in biomedical research, is an
ordinal ranking method (Helsel, 2012). This method incorporates information on the intensity
level, by using the ranks of the data in order to preserve the information on the ordering of
the detected intensities. The intensities corresponding to the same biological peak are ranked
separately. Ranks of data tied to the same value are themselves tied to a value equal to the
average of the ranks they would have had if there had been no ties. After ranking the intensities
across samples, the observed data are replaced with their ranks. To have one unique value per
cluster, we define our summary measure as the sum of the resulting ranks R1, ...,RJ within
each cluster for each patient, given by SR = ∑ jR j. Alternatively, we may consider as our
summary measure the rank at the cluster maximum, given by MR= R j(m), where j(m) denotes
the position where l¯ j is maximum and hence fixed across patients.
Quantile method An other method which uses information across all available samples is
quantile normalization. This method is commonly used in genomics research for microarray
data preprocessing (Bolstad et al., 2003). We propose to use the quantile method to make
the distribution of peak intensities across different samples comparable. More specifically,
each sample is given the same distribution by estimating the mean quantile across samples
and substituting this as the value of the intensity in the original data set. To achieve this, we
first assign an index to each intensity value within each sample. Subsequently, we sort all
samples by their intensities and substitute each sorted intensity in each sample with the mean
of the sorted intensities across samples. The normalized intensity for each peak is derived
by restoring the original order of the assigned indexes for each sample. We may consider as
our summary measure, either the sum of the resulting normalized intensities Q1, ...,QJ within
each cluster for each patient, given by SQ = ∑ jQ j, or the normalized intensity at the cluster
maximum, given by MQ= Q j(m).
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Sum of log-intensities A simple measure to summarize the isotopic expression while us-
ing the complete information on the intensity level across samples is to sum all peak intensities
within the same cluster for each patient. We consider the log scale instead of the original scale
which is known to be an appropriate scale for mass spectrometry data (Sauve and Speed, 2004).
We define our intensity measure for each patient and each cluster as the sum of log-transformed
peak intensities, given by SL= ∑ j l j.
Maximum log-intensity Alternative to using the sum of all (log-transformed) intensities
as summary measure is to use only the intensity at the cluster maximum. We define the inten-
sity at the cluster maximum for each cluster and each patient as ML= l j(m).
2.3.2 Shape summary measures
In what follows, we propose different summary measures which aim to estimate the shape of
the observed isotopic cluster pattern for each patient. Note that all our shape summary mea-
sures are invariant under adding a constant to the log intensities or multiplying all intensities
of a isotopic cluster in a patient with a factor. Hence, on a conceptual level, they do not carry
any information on the intensity level.
Defining residuals suitable for shape investigation Alternatively to considering the
observed isotopic cluster pattern directly, we may investigate the deviation of that observed
pattern from the typical pattern. We define the typical pattern - as before - as the average
of the log-intensities across samples given by: l¯ j := 1n ∑i l ji . We define the corresponding
typical pattern for the absolute intensities by the back transformation y¯ j := exp(l¯ j). To evaluate
the deviation between y1, ...,yJ and y¯1, ..., y¯J , while accounting for the fact that absolute peak
intensities can vary greatly across isotopes and between samples, we scale up y¯1, ..., y¯J by
a factor β . To determine β , we first consider the relationship α = logβ . We choose α to
minimize ∑i(l ji− l¯ ji−α)2, resulting in α = 1J
J
∑
j=1
(l j− l¯ j) and β = exp(α) = exp
(
1
J
) J
∏
j=1
y j
y¯ j
=(
J
∏
j=1
y j
y¯ j
) 1
J
, the geometric mean of y jy¯ j . In this way, we obtain the residuals s j = l j − l¯ j −α
and r j = exp(s j) =
y j
y¯ jβ . In the following, we describe summary measures based on shape as a
function of x j, j = 1, ...,J where x j may be either one of the choices y j, l j, r j or s j.
Pairwise ratios or differences A simple and straightforward approach to evaluate shape
information is to look at the pairwise ratios Q j j′ =
x j
x j′
. We can either use all pairwise ratios
as input or just a selection. For instance, we can use the consecutive ratios Q12,Q23, ...,QJ−1J
or choose Q j(1) j(2) with j(1) the position with maximum y¯ j and j(2) the position with second
maximum y¯ j. Pairwise ratios can be calculated for either i or r. The analogous measure for l
or r is to use the pairwise differences ∆ j j′ = x j− x j′ .
Peak location and related measures Information on the shape can also be extracted by
examining the position of the mode of the cluster pattern distribution or the relative position of
all values in the ordering as to the position of the mode. Let R1, ...,RJ be the ranks of x1, ...,xJ .
The vector R1, ...,RJ is itself a measure that provides information about the shape. Let now
R−1(1), ...,R−1(J) be the inverse ranks, such that R(R−1( j)) = j. Then R−1(J) is the location
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of the peak (mode) of the cluster pattern distribution which is itself a measure which contains
information on the shape. We may also use the entire vector R−1(J), R−1(J−1), ...,R−1(1) as
input or a subset R−1(J), R−1(J−1), ...,R−1(J− k). These shape measures can be applied to
either one of y, j, r or s.
Distributional shape An isotopic cluster as shown in Figure 1 bears resemblance to a
histogram. Therefore, we may regard the values x1, ...,xJ as heights of this histogram, for a
distribution on the values 1, ...,J, and consider some characteristics of this distribution. To do
that we first define the center of gravity of a distribution as
cg :=∑
j
jp j
where p j :=
x j
∑ j x j
. The center of gravity is already a measure which carries information on
the shape of the distribution and can therefore itself be used as a summary measure. Further-
more, we consider the following distributional shape measures: 1) spread, which measures the
amount of variation or dispersion of the distribution, 2) skewness, which measures the asym-
metry of the distribution and 3) kurtosis, which measures the peakedness of the distribution,
based on the following definitions:
spread :=
√
∑
j
( j− cg)2p j
skewness :=
∑ j( j− cg)3p j(
∑ j( j− cg)2p j
)3/2
kurtosis :=
∑ j( j− cg)4p j(
∑ j( j− cg)2p j
)2
Note that these definitions can be applied to any distribution defined on at least two points and
are hence applicable to all clusters. Since x1, ...,xJ need to be positive, the above measures can
be derived in principle either for y or r.
Tendencies in the residuals An alternative way to extract information on the isotopic
cluster pattern is to examine the behavior of the residuals along the isotopic path. For instance
we may investigate possible tendencies for the residuals to increase or decrease with j, or ten-
dencies for the residuals to be higher in the middle or higher at the borders/tails of the isotopic
cluster pattern distribution. To conduct these investigations we fit the orthogonal polynomial
x j = α+β
(
j− J¯)+ γ( j− J¯)2 + ε j
We choose α , β and γ to minimize
∑
j
(
x j−
(
α+β
(
j− J¯)+ γ( j− J¯)2))2
We use the estimates of β and γ as our summary measure. This approach requires J ≥ 3 and
can be applied to either one of r or s.
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3 Application and analysis
3.1 Identification algorithm implementation
We applied the identification algorithm to the individual raw spectra, to obtain the condensed
data set used to derive the summary measures. The algorithm was implemented in Matlab using
programmes developed by the authors. All functions used can be found in the supplementary
file (Additional file 1). The concrete values of our algorithm thresholds are specific for our
data and were chosen on the basis of visual inspection of the individual spectra and random
testing. In particular, the threshold introduced in the first step of the algorithm, to identify peak
locations, was set equal to 0.8×106, which corresponds to the estimated average spectra noise
threshold. We choose the distance δ of our basic relation in the cluster identification step to be
equal to 0.08 which was proved to be a fairly reasonable choice. This distance is an important
adjusting parameter in our procedure and one should try to vary it and examine the results
visually. Finally, we choose δ ′ to be equal to 0.1, which was found to be the proper value for
ensuring a minimal distance of 0.5 between the resulting intervals representing consecutive
peaks.
From the resulting list of clusters, we discarded those which were more likely to correspond
to joined isotopes. We did so by removing the clusters found with more than 8 peaks and more
than 1 local maxima. This resulted in a total of 2717 identified isotopic clusters and 8080
isotopic peaks. The average size of the identified clusters is 3.3 peaks, while the minimum
and maximum sizes are 2 and 10 peaks respectively. Of the identified clusters and peaks, only
a small number was identifiable in all samples. The resulting data set contained thus a large
proportion of undetectable peaks (85 %). Figure 3 shows a graphical representation of the
magnitude of incomplete isotopic expression, at the cluster and the peak level separately.
3.2 Model fitting and results
To evaluate the impact of the different summary measures on class calibration and prediction,
we fit a model each time using one of the summary measures as input variables and we evaluate
the predictive performance and predictive accuracy of each such fit. We should mention at this
point that shape summary measures were derived solely for detected or partly detected clusters.
In case an entire cluster is undetectable in a sample, we impute the average value of the derived
shape measure across all samples, prior to fitting the model.
We choose to use ridge logistic regression as our classifier, which is a well established
method in applied sciences and classification literature and proved effective in high dimensions
(Le Cessie and van Houwelingen, 1992). This method is commonly used in situations where
the number of covariates exceeds the number of observations and/or there are high correlations
between them. Ridge logistic regression shrinks the regression coefficients towards zero by
imposing a penalty on their size.
Our procedure consists of two phases. The first phase can be considered as a type of
internal validation. During this phase, we re-define the calibration-validation structure, using
random splitting, in order to obtain more robust results. We randomly assign each observation
to one of two sets as follows: we begin by selecting a case from the overall set of samples
and assigning it to one of two sets. Since the case-control ratio in each plate was 1/2, for
each selected case, two controls from the same plate are assigned to the same set as that case.
In this way we preserve the plate information. This random splitting is repeated 10 times.
Classification results across repetitions are finally averaged to obtain more stable estimates. To
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evaluate and compare the predictive ability of each model using each summary measure, we
begin with a double-cross validatory approach, within the re-defined calibration set, consisting
of two nested loops (Mertens et al., 2006, Stone, 1974). The inner loop is used to determine the
optimal tuning parameter, while the outer loop is used to estimate the predictive performance
of the approach across all observations, by applying the chosen optimized rules from the inner
loop to the left-out datum. To evaluate performance of the final diagnostic rule on the set aside
validation set, we perform leave-one-out cross validation to the calibration set to estimate the
optimal tuning parameter and we apply the resulting rule to the separate validation set. All the
computations were carried out in Matlab using programs written by the authors.
Table 1 shows estimates of the predictive performance measures of the ridge logistic model
fitted to each intensity measure, for the calibration and validation sets, together with their
standard errors. For each model we calculate the error-rate and the area under the ROC curve
(AUC). To evaluate the accuracy of each fit, we also calculate the Brier score and the deviance,
defined as
Brier score =
1
n
n
∑
i=1
(pˆi− ci)2
Deviance = −2
n
∑
i=1
ci log pˆi+(1− ci)(log(1− pˆi)
= −2
n
∑
i=1
log(1−|pˆi− ci|)
where pˆi is the estimated probability of being a case for the ith individual, ci is the known health
status of that individual and n is the total sample size. For class assignments, we use a threshold
of 0.5 and thus assign an observation as a disease case if the estimated class probability pˆi is
greater than 0.5 and as a control otherwise.
Classification results, using the binary indicator as our only predictor, suggest that the
present/absent status, either at the peak (BP) or at the cluster (BC) level, is highly informative
with regards to the class outcome. Using the sum of intensity ranks (SR) as summary measure
seems to be recovering information on top of the present/absent information, which results in
improved predictions compared to BP and BC. Looking at the overall results, we find best clas-
sification performance achieved when using the sum of quantile normalized intensities (SQ)
or the sum of log-intensities (SL) as summary measures. The ranking method and the quantile
normalization share the characteristic that summary measures on one observation are based on
borrowing information across all available observations. Quantile normalization is a widely
used pre-processing procedure applied to genomic data in order to remove technological noise
and has been proved to give favorable results in differential expression analysis. Moreover, we
observe that using solely the values at the cluster maximum, to summarize the entire isotopic
expression, does not capture the entire information in the overall intensity level. This becomes
clear looking at validated classification results based on the max log-intensity (ML), the max
rank intensity (MR) and the max quantile normalized intensity (MQ). These results confirm
that the above measures are less powerful, in terms of predictive ability, compare to summary
measures based on cumulative cluster information, such as the sum of log-intensities (SL), the
sum of rank intensities(SR) or the sum of quantile normalized intensities (SQ).
In Table 2 we report estimates of the predictive performance measures based on shape
summary measures, calculated on the vector of residuals r. We choose to present results based
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on r, on the one hand, because all the proposed shape measures are applicable to r, and on
the other, because shape measures calculated on r provided slightly better results compared to
shape measures calculated on y, l or s. Results based on a collection of shape measures calcu-
lated on y, l and s can be found in the supplementary file (Additional file 2). The conclusion
which can be drawn from this data analysis is that, on average, the observed isotopic cluster
patterns differ in shape between healthy and diseased individuals. In particular, the center of
gravity of the distribution of the residuals (cg) and the spread of the residuals (spread) which
measures the deviation from the expected isotopic pattern conditional on relative position j,
are the shape measures which provided the best classification results with error rates 0.177
and 0.175 respectively. Predictive performance measures using the vector of the ranks of the
residuals (R) or the vector of the inverse ranks of the residuals (R−1) are fairly close to results
using the center of gravity or the spread of the distribution of residuals, suggesting that the
overall pattern of deviation varies between the two groups. Comparing the results obtained
using intensity measures to the ones obtained using shape measures, we can conclude that in-
formation on the intensity level has a higher predictive potential, as compared to information
on the isotopic cluster shape. Nevertheless, classification results using the center of gravity or
the spread of the distribution of residuals in particular, are fairly close to those obtained using
the majority of intensity summary measures.
The second phase of our evaluation procedure constitutes a type of external validation.
During this second phase, we build the prediction model using each summary measure on
the calibration set, as defined in the original experiment, and evaluate the resulting rule on
the separate validation set, following the same cross-validatory approach as in the first phase.
Classification results based on intensity summary measures for the original calibration and
validation sets are presented in Table 3. The ranking of the intensity measures, with respect
to their predictive performance, is in agreement with the average ranking using the redefined
calibration-validation structure. Classification results based on a collection of shape summary
measures are presented in Table 4 in which we observe again a ranking of the measures similar
to the internal calibration.
A remark worth mentioning at this point lies in the fact that classification results for some
summary measures, go into an unexpected direction. That is, we occasionally observe better
discrimination in the validation set than in the calibration set. A possible explanation of this
phenomenon is the fact that the samples for the calibration set were collected in an earlier
period than the samples for the validation set and were stored long before they were actually
processed by the mass spectrometer. This resulted in a considerable aging of the calibration
samples on which the discriminating rule was based. In spite of this aging, it looks like the
ridge model was able to construct a reasonable rule, which worked better on samples not
affected by the aging.
To evaluate if the proposed shape summary measures have predictive ability in their own
right and are independent of any information related to the overall intensity level, we estimate
the added value of shape over intensity. We regress, for each cluster separately, shape on
intensity and use the residuals of that fit to predict the class outcome. For flexibility, we
choose to use cubic splines to model the relationship between shape and intensity. The key
idea of this approach is to discard the shared information between shape and intensity and
use the remaining residual information, which is independent of the overall intensity level,
to assess the predictive ability of shape. Putting the isolated information of shape into our
prediction model resulted in an error rate of 0.27 and 0.28 (AUC of 0.77 and 0.78), for the
calibration and validation sets respectively, which are smaller than the error-rates (larger than
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the AUCs) we would expect to occur by chance. This outcome suggests that the shape of the
observed isotopic cluster pattern holds information, with regard to classification, independent
of the overall intensity level.
We finally investigate whether we can enhance the predictive performance of our diagnostic
rule by integrating both types of information. We choose the sum of log-intensities as the
intensity measure to be combined with a shape measure. Combining SL and cg resulted in
an average error-rate of 0.097 and 0.107 for the calibration and validation sets respectively.
Hence, the combination of these measures does not result in prediction improvement, despite of
our previous finding that the two different types of information are “conceptually independent”
and have predictive power in their own right. Similar outcomes occurred when combing SL
and R, SL and R−1, SL and spread, SL and skew as well as SL and kurt. These results suggest
that the additional value of shape information is actually so small that ridge regression cannot
make use of it when confronted with the task of selecting information from both intensity and
shape measures.
4 Discussion
Here we have presented a statistical report in which we considered the problem of summariz-
ing and analyzing high-throughput mass spectrometry data in an appropriate and meaningful
way. To this end, a fast and simple procedure to preprocess the individual spectra prior to
summarizing and analyzing the acquired data was proposed. We have presented simple sum-
mary measures which can be used as input variables for the construction of prediction rules
for disease status allocation of future patients. These summary measures were based on using
information on the intensity level or the shape of the observed isotopic cluster pattern. An
extensive evaluation of the proposed measures was performed with respect to their predictive
ability. Results using these measures indicated that both the intensity level and the isotopic
cluster shape are related to the class outcome and can be used to predict the presence or ab-
sence of the disease. It was noted that summary measures based on shape were less informative
in terms of predictive potential when compared to summary measures based on intensity level.
Previously, various algorithms have been reported to de-isotope and preprocess high-resolution
mass spectral data (Senko et al., 1995, Rockwood and Haimi, 2006, Palmblad et al., 2001,
Valkenborg et al., 2012, van der Burgt et al., 2007). In particular the idea of using the 1 mass
unit distance to identify isotopes can be found in Horn et al. (2000) and Park et al. (2008). The
approach described in Horn et al. is applicable to a single spectrum and it is based on determin-
ing best fitting local models. This computationally intensive task is avoided in our algorithm
by using information across all potential isotopic peaks across all patients. Hence the algo-
rithm we propose can be applied fast across many spectra from different patients. This renders
the approach more suitable for clinical applications. Since our algorithm is based solely on the
distance along the m/z-axis, it has the limitation that (occasionally) distinct isotope distribu-
tions can be joined into the same cluster. The proposed algorithm is specific to this particular
type of data and can be applied to spectra containing singly charged ions resulting in a distance
of 1 Da between successive isotopic peaks. As mentioned in the Introduction section, electro-
spray ionization (ESI) yields multiply charged ions, resulting in a reduced distance inversely
proportional to the number of charges on the molecule. Applying the identification algorithm
to spectra containing multiply charged ions therefore requires appropriate adjustments.
A crucial component in our data was the large number of (unidentified) peaks (or clusters),
which is a common outcome in many FTICR-MS clinical applications. For this reason, we
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decided to start our investigations by evaluating whether the presence/absence mechanisms
of the isotopic expression are associated with the class outcome. Results from this investi-
gation showed that the binary indicator, either at the peak or at the cluster level, is itself a
good predictor of the case-control outcome, suggesting the present/absent patterns are differ-
ent between the two groups. Incorporating additional information on the intensity level, by
using for instance the ranks of the data, in order to preserve the information on the ordering
of the detected intensities provided improved estimates compared to using information on the
presence/absence status only.
While intensity measures as discussed in this paper can vary in their complexity, they were
all proved to be highly informative with regards to the case-control outcome. Intensity mea-
sures were based on the log transformed peak intensities as this is considered an appropriate
scale for high-throughput mass spectrometry data which often cover a large range of values,
spanning several orders of magnitude. Nevertheless, intensity measures presented in this paper
can be derived using either log or raw intensities.
A second objective of this research was to investigate whether there is additional informa-
tion in the shape of the observed isotopic cluster pattern, related to the case-control outcome
which is independent of information in the intensity level. We proposed several measures to
carry out these investigations, applied either to the observed isotopic cluster pattern directly
or applied to the residuals measuring the deviation of that observed pattern from the expected
one. In contrast to intensity summary measures, we consider shape measures based both on
log and raw peak intensities, since the latter defines the original shape of the observed isotopic
cluster pattern. Results based on these measures indicated that the shape of the observed iso-
topic cluster pattern is predictive of the class outcome, yet less informative as compared to the
overall intensity level. While this finding may appear odd at first sight, since isotopes could
be hypothesised to have a fixed shape distribution, the observed shape effect may be explained
by the occurrence of overlapping compounds within one isotopic cluster (Senko et al., 1995,
Burzykowski et al., to appear). For instance, in case of two overlapping compounds differing
by exactly 1 Da (measured as one m/z-unit difference) we actually analyse by our approach the
sum of two isotopic distributions. We emphasize at this point that it is very unlikely that the
observed shape differences are the result of the measurement procedure itself, since both cases
and controls samples were randomly allocated within the plates. However, linking biological
explanations to the observed shape effect is/must be a topic of future research.
In order to understand the true value of the derived shape measures on top of the intensity
level, we isolated the information not shared between shape and intensity and use this to predict
the class outcome. Results indicated that the remaining information, after removing the one
which was shared, has still predictive power in its own right. Nevertheless, the additional
value of shape information was insufficient as to allow for improved predictions when being
combined with information on the intensity level. As an alternative to combining intensity
and shape measures into the same model, we explored the predictive potential of combining
shape and intensity, by including all single peaks into the ridge model, allowing thus the model
to pick up the most interesting combinations. The outcome of this procedure was similar to
the one obtained when combining a shape with an intensity measure, which did not provide
improved predictions.
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Table 3: Results based on intensity measures for calibration and validation sets as defined in orig-
inal experiment.
Calibration set (as defined in original experiment)
BP BC SR MR SQ MQ SL ML
Error-rate 0.126 0.133 0.120 0.147 0.133 0.133 0.133 0.120
Brier score 0.097 0.105 0.093 0.114 0.088 0.096 0.088 0.095
Deviance 101.37 110.07 91.05 113.92 91.16 95.65 90.12 94.35
AUC 0.907 0.892 0.936 0.888 0.936 0.925 0.934 0.925
Validation set (as defined in original experiment)
BP BC SR MR SQ MQ SL ML
Error-rate 0.153 0.163 0.115 0.173 0.096 0.125 0.096 0.125
Brier score 0.107 0.113 0.088 0.122 0.082 0.089 0.077 0.086
Deviance 72.59 80.41 63.49 80.53 58.93 60.99 53.33 58.05
AUC 0.942 0.925 0.945 0.926 0.964 0.971 0.973 0.975
BP, binary peak indicator; BC, binary cluster indicator; SR, sum of rank intensities;
MR, max rank intensity; SQ, sum of quantile normalized intensities; MQ, max
quantile normalized intensity; SL, sum of log-intensities; ML, max log-intensity.
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Table 4: Results based on shape measures (calculated on raw intensity residuals) for calibration
and validation sets as defined in original experiment.
Calibration set (as defined in original experiment)
R R−1 cg spread skew kurt
Error-rate 0.226 0.220 0.160 0.180 0.213 0.273
Brier score 0.166 0.140 0.123 0.121 0.139 0.186
Deviance 151.36 128.54 120.72 120.02 128.36 169.07
AUC 0.792 0.865 0.872 0.875 0.863 0.670
Validation set (as defined in original experiment)
R R−1 cg spread skew kurt
Error-rate 0.230 0.163 0.182 0.182 0.192 0.298
Brier score 0.161 0.139 0.120 0.120 0.148 0.198
Deviance 102.32 91.12 78.76 78.69 97.21 121.07
AUC 0.836 0.858 0.899 0.896 0.841 0.699
R, vector of ranks of residuals; R−1, vector of inverse ranks of residuals; cg, cen-
ter of gravity of distribution of residuals; spread, spread; skew, skewness; kurt,
kurtosis of distribution of residuals based on relative position j.
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Figure 1: The mass spectrum of a single individual. Superimposed is shown an isotopic cluster at
position m/z 2021.2.
21
Figure 2: An identified isotopic cluster at 2553 m/z for three different samples. The isotopic
cluster is completely observed in the first sample, only partly observed in the second sample and
completely non-observed in the third sample.
22
Figure 3: Presence/absence magnitude at cluster (left) and peak (right) level. Proportion of entirely
undetectable clusters (left plot) and proportion of undetectable peaks (right plot).
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